Member-only story

Changing The Way We Do Medicine: MedTech Disruptor Announces Earnings, Milestones and Platform Capabilities

Jessica N. Abraham
13 min readApr 15, 2022

--

Medtech disruptor, QHSLab, QHSLabs, Troy J. Grogan, Biotricity, Teledoc, Medical Device, Technology, Finance, Business, allergies, comorbities, asthma, lung disease, cancer, heart disease, cardiovascular, remote doctors appointments, GoodRX, finance, otcmarkets, stocks, stroke, heart attacks
Image via mohamed_hassan on Pixabay

The U.S. is the largest medical device market in the world, making up 40% of the global medical device market overall. By 2023, it’s expected to grow to $208 billion as global markets soar to all-time highs. Lockdowns and telemedicine referrals drove the global arena to hit $432 billion in just two years, sending the entire industry on course to reach $658 billion by 2028.

Although Teladoc appointments existed long before the Covid-19 pandemic, it wasn’t until the world went into a lockdown that most people started to avoid the doctor’s office altogether. Some feared catching the virus just by going in for a routine appointment. Others just didn’t want to take a chance leaving the house because not much was understood about its transmission.

No One Was Ready for Digital Medicine… Until They Were.

Digital medicine has inadvertently broadened the scope and capabilities of independent health care practices and providers. For a good majority of the pandemic, some offices avoided booking in-person visits altogether, attempting to minimize the potential spread of the coronavirus.

Teladoc services began to thrive. And while some practices just found it to be…

--

--

Jessica N. Abraham
Jessica N. Abraham

Written by Jessica N. Abraham

Jessica N. Abraham writes about Business, Technology and Career Development. https://www.jessicanabraham.com | Twitter: @jessicanabraham

No responses yet